STAT — Reporting from the frontiers of health and medicine
- First Opinion STAT Plus: An overlooked way to make participants in clinical trials look more like America
- Health Some hoped a new oral vaccine would solve all the polio campaign’s problems. Reality is settling in
- Pharmalot STAT Plus: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
- Exclusive STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
- Business STAT Plus: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments
- Pharma STAT Plus: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
- The Readout LOUD Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
- First Opinion STAT Plus: An overlooked way to make participants in clinical trials look more like America
- Health Some hoped a new oral vaccine would solve all the polio campaign’s problems. Reality is settling in
- Pharmalot STAT Plus: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
- Exclusive STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
- Business STAT Plus: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments
- Pharma STAT Plus: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
- The Readout LOUD Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
Exclusive analysis of biotech, pharma, and the life sciences
-
STAT Plus: Boston Scientific cancels $230 million deal to buy Korean device company
-
STAT Plus: Seagen criticized by shareholder advisory firm for ‘problematic’ executive compensation ahead of Pfizer acquisition
-
STAT Plus: Supreme Court rules against Amgen in closely watched case over scope of patent claims
- Pharmalot ‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
- First Opinion How Tennessee is creating new opportunities for doctors trained outside the U.S.
- Health Why fentanyl is deadlier than heroin, in a single photo
-
- First Opinion STAT Plus: An overlooked way to make participants in clinical trials look more like America
- Health STAT Plus: Addiction treatment center founder indicted in sprawling fraud scheme
- Health Tech STAT Plus: What does generative AI mean for health care? We asked the experts
- First Opinion Cancer patients shouldn’t be responsible for out-of-pocket costs
- Health Texas wants to wean trans youth off meds in a ‘safe and medically appropriate’ way. Doctors say that’s impossible
- Health New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
